Today's celebration of Novartis' new flu vaccine plant marks more than just the completion of a building.
One milestone is part science and part public health.
The plant is the nation's first facility to use ingredients cultured in cells - not injected into eggs - to produce flu vaccine. This method is proving to be a safer and faster way to respond to flu pandemic.
Second, the plant will bring jobs to Holly Springs. As many as 350. Read one employee's story.
Finally, it marks the end of a long, often uncertain economic development process. Listen as Bill Bullock, the Center's point person for recruitment, talks about what goes into recruiting a facility like Novartis'.
Posted Nov. 24, 2009
